Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study
The randomized controlled trial titled “Dehydroepiandrosterone supplementation enhances immune function in HIV-positive subjects with undetectable viral load” (Clinical Infectious Diseases, 2007, PMID: 17263636) investigated whether supplementation with dehydroepiandrosterone (DHEA) could influence HIV replication and immune function. The study found that DHEA did not significantly alter viral load or CD4+ T-cell